BAVENO VII门静脉高压共识更新:门静脉高压的个体化治疗

来源 :中华肝脏病杂志 | 被引量 : 0次 | 上传用户:xsw2233
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
2021年10月召开的Baveno Ⅶ共识会的主题是“门静脉高压的个体化治疗”。主要讨论了9个主题,包括:把测量肝静脉压力梯度作为诊断金标准;非侵入性方法诊断代偿进展期慢性肝病和临床有意义的门静脉高压;病因治疗和非病因治疗对肝硬化的影响;预防首次失代偿;急性静脉曲张出血;预防进一步失代偿;以及内脏静脉血栓和其他肝脏血管病。本文对上述主题的推荐进行编译汇总,把国际上门静脉高压最前沿的研究成果和借此形成的共识意见呈现给读者。“,”The Baveno VII workshop held in October 2021 was featured by the subject of personalized care in portal hypertension. The workshop focused on the following 9 topics including: the relevance and indications for measuring the hepatic venous pressure gradient as a gold standard; the use of non-invasive tools for the diagnosis of compensated advanced chronic liver disease and clinically significant portal hypertension; the impact of etiological and of non-etiological therapies in the course of cirrhosis; the prevention of the first episode of decompensation; the management of the acute bleeding episode; the prevention of further decompensation; as well as the diagnosis and management of splanchnic vein thrombosis and other vascular disorders of the liver. This essay provides a compilation and summary of recommendations regarding the abovementioned topics, and presents the most recent research proceedings and the corresponding consensus to our readers.
其他文献
为帮助肝病相关临床医师在肝豆状核变性诊断和治疗中做出合理决策,中华医学会肝病学分会遗传代谢性肝病协作组于2021年组织国内相关领域专家,以肝豆状核变性的临床和基础研究进展为依据,共同编写了该《肝豆状核变性诊疗指南(2022年版)》。“,”In order to help liver disease-related clinicians make reasonable decisions for the diagnosis and treatment of hepatolenticular degenera